Florida Cancer Specialists

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Metastatic breast cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting4 trials

Lead sponsor

• Pfizer2 trials
• Seagen, a wholly owned subsidiary of Pfizer2 trials

Running trials

• Active, not recruiting

  A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer

  NCT05654623· Phase 3· Pfizer· Source

• Recruiting

  A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

  NCT04879329· Phase 2· Seagen, a wholly owned subsidiary of Pfizer· Source

• Active, not recruiting

  Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

  NCT04404283· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source

• Active, not recruiting

  Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC

  NCT03395197· Phase 3· Pfizer· Source